Australian Pharm. (ASX:API)
Historical Yield (%)
Short Sell (%)
GICS Industry Group
GICS Sub-Industry Group
EBITDA Margin (%)
EBIT Margin (%)
NPAT Margin (%)
Net Gearing (%)
Net Interest Cover
About Australian Pharm. (API.AX)
Research & News
- 33 Stocks on the ASX 200 To Watch This Week [20 Sep 2021] September 20, 2021 - The Australian markets had a roller-coaster week, reacting to a mix of good and bad news. However, the ASX200, ASX300, and the Ordinaries all ended the week down 0.2%. The centrepiece news was the massive tumble in iron ore prices owing to actions from China. On the other hand, markets were comforted by the RBA’s… Continue Reading
Are you looking for the best stocks to buy in 2021? We’ve put together a free report on 5 stocks that we think are the best buys on the ASX right now. Download it instantly here.
Information is provided ‘as is’ and solely for information purposes, not for trading purposes or advice.
Want more Free Research?
Subscribe today for free and get an email with stocks to watch every Monday and new research every Thursday.
MF & Co. Asset Management
MF & Co. Asset Management is a boutique investment firm offering Equity Capital Markets and derivative general advice & trade execution services.
We are specialists in advising and trading in Australian and US Equities, Index & Equity Options and Options on Futures.